Clinical Trial Update: SCLERoderma et Adipose-DErived Stroma Cells [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating adipose-derived stromal cells for systemic sclerosis; current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Drugs mentioned

• Adipose-Derived Stromal Cells (adipose-derived stromal cells)

Snippet

Sponsor: Assistance Publique Hopitaux De Marseille | Conditions: Systemic Sclerosis | Phase 2 | Status: UNKNOWN